UBS Group »

Onkure Therapeutics Inc-a shares owned by UBS Group

Quarter-by-quarter ownership of Onkure Therapeutics Inc-a (OKUR) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Onkure Therapeutics Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Onkure Therapeutics Inc-a held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Onkure Therapeutics Inc-a by UBS Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $563 205 2.75
2025-06-30 $433 181 2.39
2025-03-31 $1.2k 280 4.30
2024-12-31 $19k 2.2k 8.60

More positions owned by UBS Group

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Ubs Group SHS (UBS)
Tesla Motors (TSLA)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A (V)

View all positions for UBS Group

Top funds holding Onkure Therapeutics Inc-a

Acorn Capital Advisors
Citadel Advisors
Shay Capital
Vanguard Group
Highbridge Capital Management
Vestal Point Capital
BlackRock
StepStone
Cantor Fitzgerald, L. P.
NEA Management Company
Carlyle
Prosight Management
Renaissance Technologies
Rangeley Capital
Tang Capital Management

View all funds holding Onkure Therapeutics Inc-a